Macrophage Inflammatory Protein-1 Beta and Interferon Gamma Responses in Ugandans with HIV-1 Acute/Early Infections
Control of HIV replication through CD4(+) and CD8(+) T cells might be possible, but the functional and phenotypic characteristics of such cells are not defined. Among cytokines produced by T cells, CCR5 ligands, including macrophage inflammatory protein-1 beta (MIP-1β), compete for the CCR5 corecept...
Gespeichert in:
Veröffentlicht in: | AIDS research and human retroviruses 2016-03, Vol.32 (3), p.237-246 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 246 |
---|---|
container_issue | 3 |
container_start_page | 237 |
container_title | AIDS research and human retroviruses |
container_volume | 32 |
creator | Obuku, Andrew Ekii Bugembe, Daniel L Musinguzi, Kenneth Watera, Christine Serwanga, Jennifer Ndembi, Nicaise Levin, Jonathan Kaleebu, Pontiano Pala, Pietro |
description | Control of HIV replication through CD4(+) and CD8(+) T cells might be possible, but the functional and phenotypic characteristics of such cells are not defined. Among cytokines produced by T cells, CCR5 ligands, including macrophage inflammatory protein-1 beta (MIP-1β), compete for the CCR5 coreceptor with HIV, promoting CCR5 internalization and decreasing its availability for virus binding. Interferon (IFN)-γ also has some antiviral activity and has been used as a read-out for T cell immunogenicity. We used cultured ELISpot assays to compare the relative contribution of MIP-1β and IFN-γ to HIV-specific responses. The magnitude of responses was 1.36 times higher for MIP-1β compared to IFN-γ. The breadth of the MIP-1β response (45.41%) was significantly higher than IFN-γ (36.88%), with considerable overlap between the peptide pools that stimulated both MIP-1β and IFN-γ production. Subtype A and D cross-reactive responses were observed both at stimulation and test level, but MIP-1β and IFN-γ responses displayed different effect patterns. We conclude that the MIP-1β ELISpot would be a useful complement to the evaluation of the immunogenicity of HIV vaccines and the activity of adjuvants. |
doi_str_mv | 10.1089/aid.2015.0157 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1859481086</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1859481086</sourcerecordid><originalsourceid>FETCH-LOGICAL-c326t-ab9fbd13e68380b2859ec3254827a01ca87013542cd05d9c82296f2bfa890c173</originalsourceid><addsrcrecordid>eNqFkT1PwzAQhi0EoqUwsiKPLGltJ07ssVSlrQQCIcoaOc6lDcoXtiPUf4-jFlaGk4d7_OruHoRuKZlSIuRMlfmUEcqnvpIzNKYypIGICD9HYyKEDBhjcoSurP0khEjG-CUasZhHIiHJGNlnpU3b7dUO8KYpKlXXyrXmgF9N66BsAoofwCmsmtz3HZgCTNvg1cDhN7Bd21iwuGzwducZ1Vj8Xbo9Xm8-_Ne57h3MlspUhyEdtCs9f40uClVZuDm9E7R9XL4v1sHTy2qzmD8FOmSxC1QmiyynIcQiFCRjgkvwHT85SxShWvkNaMgjpnPCc6mFXzQuWFYoIYmmSThB98fczrRfPViX1qXVUFWqgba3KfWJkfBXjP9Hk1hwHhNBPBocUX83aw0UaWfKWplDSkk6KEm9knRQkg5KPH93iu6zGvI_-tdB-AM6pIX9</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1768556080</pqid></control><display><type>article</type><title>Macrophage Inflammatory Protein-1 Beta and Interferon Gamma Responses in Ugandans with HIV-1 Acute/Early Infections</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Obuku, Andrew Ekii ; Bugembe, Daniel L ; Musinguzi, Kenneth ; Watera, Christine ; Serwanga, Jennifer ; Ndembi, Nicaise ; Levin, Jonathan ; Kaleebu, Pontiano ; Pala, Pietro</creator><creatorcontrib>Obuku, Andrew Ekii ; Bugembe, Daniel L ; Musinguzi, Kenneth ; Watera, Christine ; Serwanga, Jennifer ; Ndembi, Nicaise ; Levin, Jonathan ; Kaleebu, Pontiano ; Pala, Pietro</creatorcontrib><description>Control of HIV replication through CD4(+) and CD8(+) T cells might be possible, but the functional and phenotypic characteristics of such cells are not defined. Among cytokines produced by T cells, CCR5 ligands, including macrophage inflammatory protein-1 beta (MIP-1β), compete for the CCR5 coreceptor with HIV, promoting CCR5 internalization and decreasing its availability for virus binding. Interferon (IFN)-γ also has some antiviral activity and has been used as a read-out for T cell immunogenicity. We used cultured ELISpot assays to compare the relative contribution of MIP-1β and IFN-γ to HIV-specific responses. The magnitude of responses was 1.36 times higher for MIP-1β compared to IFN-γ. The breadth of the MIP-1β response (45.41%) was significantly higher than IFN-γ (36.88%), with considerable overlap between the peptide pools that stimulated both MIP-1β and IFN-γ production. Subtype A and D cross-reactive responses were observed both at stimulation and test level, but MIP-1β and IFN-γ responses displayed different effect patterns. We conclude that the MIP-1β ELISpot would be a useful complement to the evaluation of the immunogenicity of HIV vaccines and the activity of adjuvants.</description><identifier>ISSN: 0889-2229</identifier><identifier>EISSN: 1931-8405</identifier><identifier>DOI: 10.1089/aid.2015.0157</identifier><identifier>PMID: 26548707</identifier><language>eng</language><publisher>United States</publisher><subject>Adolescent ; Adult ; Cells, Cultured ; Chemokine CCL4 - metabolism ; Enzyme-Linked Immunospot Assay ; Female ; HIV Infections - immunology ; HIV Infections - virology ; HIV-1 - immunology ; HIV-1 - isolation & purification ; Humans ; Interferon-gamma - metabolism ; Lentivirus ; Leukocytes, Mononuclear - immunology ; Male ; Middle Aged ; Prospective Studies ; Retroviridae ; Uganda</subject><ispartof>AIDS research and human retroviruses, 2016-03, Vol.32 (3), p.237-246</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c326t-ab9fbd13e68380b2859ec3254827a01ca87013542cd05d9c82296f2bfa890c173</citedby><cites>FETCH-LOGICAL-c326t-ab9fbd13e68380b2859ec3254827a01ca87013542cd05d9c82296f2bfa890c173</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26548707$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Obuku, Andrew Ekii</creatorcontrib><creatorcontrib>Bugembe, Daniel L</creatorcontrib><creatorcontrib>Musinguzi, Kenneth</creatorcontrib><creatorcontrib>Watera, Christine</creatorcontrib><creatorcontrib>Serwanga, Jennifer</creatorcontrib><creatorcontrib>Ndembi, Nicaise</creatorcontrib><creatorcontrib>Levin, Jonathan</creatorcontrib><creatorcontrib>Kaleebu, Pontiano</creatorcontrib><creatorcontrib>Pala, Pietro</creatorcontrib><title>Macrophage Inflammatory Protein-1 Beta and Interferon Gamma Responses in Ugandans with HIV-1 Acute/Early Infections</title><title>AIDS research and human retroviruses</title><addtitle>AIDS Res Hum Retroviruses</addtitle><description>Control of HIV replication through CD4(+) and CD8(+) T cells might be possible, but the functional and phenotypic characteristics of such cells are not defined. Among cytokines produced by T cells, CCR5 ligands, including macrophage inflammatory protein-1 beta (MIP-1β), compete for the CCR5 coreceptor with HIV, promoting CCR5 internalization and decreasing its availability for virus binding. Interferon (IFN)-γ also has some antiviral activity and has been used as a read-out for T cell immunogenicity. We used cultured ELISpot assays to compare the relative contribution of MIP-1β and IFN-γ to HIV-specific responses. The magnitude of responses was 1.36 times higher for MIP-1β compared to IFN-γ. The breadth of the MIP-1β response (45.41%) was significantly higher than IFN-γ (36.88%), with considerable overlap between the peptide pools that stimulated both MIP-1β and IFN-γ production. Subtype A and D cross-reactive responses were observed both at stimulation and test level, but MIP-1β and IFN-γ responses displayed different effect patterns. We conclude that the MIP-1β ELISpot would be a useful complement to the evaluation of the immunogenicity of HIV vaccines and the activity of adjuvants.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Cells, Cultured</subject><subject>Chemokine CCL4 - metabolism</subject><subject>Enzyme-Linked Immunospot Assay</subject><subject>Female</subject><subject>HIV Infections - immunology</subject><subject>HIV Infections - virology</subject><subject>HIV-1 - immunology</subject><subject>HIV-1 - isolation & purification</subject><subject>Humans</subject><subject>Interferon-gamma - metabolism</subject><subject>Lentivirus</subject><subject>Leukocytes, Mononuclear - immunology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Prospective Studies</subject><subject>Retroviridae</subject><subject>Uganda</subject><issn>0889-2229</issn><issn>1931-8405</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkT1PwzAQhi0EoqUwsiKPLGltJ07ssVSlrQQCIcoaOc6lDcoXtiPUf4-jFlaGk4d7_OruHoRuKZlSIuRMlfmUEcqnvpIzNKYypIGICD9HYyKEDBhjcoSurP0khEjG-CUasZhHIiHJGNlnpU3b7dUO8KYpKlXXyrXmgF9N66BsAoofwCmsmtz3HZgCTNvg1cDhN7Bd21iwuGzwducZ1Vj8Xbo9Xm8-_Ne57h3MlspUhyEdtCs9f40uClVZuDm9E7R9XL4v1sHTy2qzmD8FOmSxC1QmiyynIcQiFCRjgkvwHT85SxShWvkNaMgjpnPCc6mFXzQuWFYoIYmmSThB98fczrRfPViX1qXVUFWqgba3KfWJkfBXjP9Hk1hwHhNBPBocUX83aw0UaWfKWplDSkk6KEm9knRQkg5KPH93iu6zGvI_-tdB-AM6pIX9</recordid><startdate>201603</startdate><enddate>201603</enddate><creator>Obuku, Andrew Ekii</creator><creator>Bugembe, Daniel L</creator><creator>Musinguzi, Kenneth</creator><creator>Watera, Christine</creator><creator>Serwanga, Jennifer</creator><creator>Ndembi, Nicaise</creator><creator>Levin, Jonathan</creator><creator>Kaleebu, Pontiano</creator><creator>Pala, Pietro</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7T2</scope><scope>7T5</scope><scope>7U2</scope><scope>7U9</scope><scope>C1K</scope><scope>H94</scope></search><sort><creationdate>201603</creationdate><title>Macrophage Inflammatory Protein-1 Beta and Interferon Gamma Responses in Ugandans with HIV-1 Acute/Early Infections</title><author>Obuku, Andrew Ekii ; Bugembe, Daniel L ; Musinguzi, Kenneth ; Watera, Christine ; Serwanga, Jennifer ; Ndembi, Nicaise ; Levin, Jonathan ; Kaleebu, Pontiano ; Pala, Pietro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c326t-ab9fbd13e68380b2859ec3254827a01ca87013542cd05d9c82296f2bfa890c173</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Cells, Cultured</topic><topic>Chemokine CCL4 - metabolism</topic><topic>Enzyme-Linked Immunospot Assay</topic><topic>Female</topic><topic>HIV Infections - immunology</topic><topic>HIV Infections - virology</topic><topic>HIV-1 - immunology</topic><topic>HIV-1 - isolation & purification</topic><topic>Humans</topic><topic>Interferon-gamma - metabolism</topic><topic>Lentivirus</topic><topic>Leukocytes, Mononuclear - immunology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Prospective Studies</topic><topic>Retroviridae</topic><topic>Uganda</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Obuku, Andrew Ekii</creatorcontrib><creatorcontrib>Bugembe, Daniel L</creatorcontrib><creatorcontrib>Musinguzi, Kenneth</creatorcontrib><creatorcontrib>Watera, Christine</creatorcontrib><creatorcontrib>Serwanga, Jennifer</creatorcontrib><creatorcontrib>Ndembi, Nicaise</creatorcontrib><creatorcontrib>Levin, Jonathan</creatorcontrib><creatorcontrib>Kaleebu, Pontiano</creatorcontrib><creatorcontrib>Pala, Pietro</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Safety Science and Risk</collection><collection>Virology and AIDS Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>AIDS research and human retroviruses</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Obuku, Andrew Ekii</au><au>Bugembe, Daniel L</au><au>Musinguzi, Kenneth</au><au>Watera, Christine</au><au>Serwanga, Jennifer</au><au>Ndembi, Nicaise</au><au>Levin, Jonathan</au><au>Kaleebu, Pontiano</au><au>Pala, Pietro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Macrophage Inflammatory Protein-1 Beta and Interferon Gamma Responses in Ugandans with HIV-1 Acute/Early Infections</atitle><jtitle>AIDS research and human retroviruses</jtitle><addtitle>AIDS Res Hum Retroviruses</addtitle><date>2016-03</date><risdate>2016</risdate><volume>32</volume><issue>3</issue><spage>237</spage><epage>246</epage><pages>237-246</pages><issn>0889-2229</issn><eissn>1931-8405</eissn><abstract>Control of HIV replication through CD4(+) and CD8(+) T cells might be possible, but the functional and phenotypic characteristics of such cells are not defined. Among cytokines produced by T cells, CCR5 ligands, including macrophage inflammatory protein-1 beta (MIP-1β), compete for the CCR5 coreceptor with HIV, promoting CCR5 internalization and decreasing its availability for virus binding. Interferon (IFN)-γ also has some antiviral activity and has been used as a read-out for T cell immunogenicity. We used cultured ELISpot assays to compare the relative contribution of MIP-1β and IFN-γ to HIV-specific responses. The magnitude of responses was 1.36 times higher for MIP-1β compared to IFN-γ. The breadth of the MIP-1β response (45.41%) was significantly higher than IFN-γ (36.88%), with considerable overlap between the peptide pools that stimulated both MIP-1β and IFN-γ production. Subtype A and D cross-reactive responses were observed both at stimulation and test level, but MIP-1β and IFN-γ responses displayed different effect patterns. We conclude that the MIP-1β ELISpot would be a useful complement to the evaluation of the immunogenicity of HIV vaccines and the activity of adjuvants.</abstract><cop>United States</cop><pmid>26548707</pmid><doi>10.1089/aid.2015.0157</doi><tpages>10</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0889-2229 |
ispartof | AIDS research and human retroviruses, 2016-03, Vol.32 (3), p.237-246 |
issn | 0889-2229 1931-8405 |
language | eng |
recordid | cdi_proquest_miscellaneous_1859481086 |
source | MEDLINE; Alma/SFX Local Collection |
subjects | Adolescent Adult Cells, Cultured Chemokine CCL4 - metabolism Enzyme-Linked Immunospot Assay Female HIV Infections - immunology HIV Infections - virology HIV-1 - immunology HIV-1 - isolation & purification Humans Interferon-gamma - metabolism Lentivirus Leukocytes, Mononuclear - immunology Male Middle Aged Prospective Studies Retroviridae Uganda |
title | Macrophage Inflammatory Protein-1 Beta and Interferon Gamma Responses in Ugandans with HIV-1 Acute/Early Infections |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T06%3A34%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Macrophage%20Inflammatory%20Protein-1%20Beta%20and%20Interferon%20Gamma%20Responses%20in%20Ugandans%20with%20HIV-1%20Acute/Early%20Infections&rft.jtitle=AIDS%20research%20and%20human%20retroviruses&rft.au=Obuku,%20Andrew%20Ekii&rft.date=2016-03&rft.volume=32&rft.issue=3&rft.spage=237&rft.epage=246&rft.pages=237-246&rft.issn=0889-2229&rft.eissn=1931-8405&rft_id=info:doi/10.1089/aid.2015.0157&rft_dat=%3Cproquest_cross%3E1859481086%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1768556080&rft_id=info:pmid/26548707&rfr_iscdi=true |